Skip to main content
. 2021 Dec 29;17(4):389–397. doi: 10.5114/aic.2021.112081

Table III.

Comparison of safety and efficacy outcomes between current study utilizing superficial transcubital venous access and notable studies using jugular and/or femoral access for catheter-directed thrombolysis in acute pulmonary embolism

Variable Jugular access Femoral access Cubital access
ULTIMA study [27]
Femoral vein
N = 30 pts
100% placement success
No major bleeding
3 minor bleeding events (10%)
SEATTLE II study [28]
Common femoral vein in 85.6% of cases
N = 150 pts
97.5% placement success
16 major bleeding events within 72 h of procedure (10.7%)
14 GUSTO moderate bleeding events (9.3%)
Pelliccia et al. [29]
Femoral vein
Percutaneous rheolytic thrombectomy
N = 33 pts
97% procedural success
No major bleeding events
9 transient periprocedural side effects (27.2%)
4 (12.1%) cases of anemia
PERFECT study [30]
Jugular or femoral access
N = 101 pts
Transjugular or transfemoral access:
85.7% clinical success in massive PE
97.3% clinical success in submassive PE
12.9% of minor bleeding events
No major procedure-related complications, no major bleeding and no hemorrhagic strokes
Present study
Superficial cubital vein
N = 27
100% clinical success
2 (7.4%) bleeding events that required physician intervention
No procedure-related complications, no major bleeding or hemorrhagic strokes